SLIT ABS: Study on Patients With Autoimmune Podocytopathy

Recruiting now · Not applicable

Conditions studied: Nephrotic Syndrome With Edema (Diagnosis), Minimal Change Nephrotic Syndrome, Focal Segmental Glomerulosclerosis (FSGS), Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy

In brief

Nephrotic syndrome is a kidney condition that mainly affects children and is characterized by high levels of protein in the urine, low levels of protein in the blood, and swelling. While many children respond well to steroid treatment, a large proportion experience relapses or become dependent on therapy. In some cases, the disease does not respond to standard treatments and may progress to chronic kidney disease. Recent research suggests that, in addition to genetic factors, immune system mechanisms may play a key role in the development and progression of nephrotic syndrome. In particular, some patients produce autoantibodies against nephrin, an essential protein of the kidney filtration barrier. These autoantibodies may be associated with disease activity and treatment response. The aim of this study is to investigate the presence of anti-nephrin autoantibodies in children with nephrotic syndrome and to better understand their role in disease mechanisms and clinical outcomes.The study will also explore the presence of other autoantibodies targeting components of the glomerular filtration barrier. The study will use advanced laboratory techniques, including blood tests and detailed analysis of kidney biopsy samples, to identify these antibodies and their relationship with kidney structure and function. By integrating laboratory findings with clinical data, this study aims to improve the understanding of nephrotic syndrome and support the development of more personalized diagnostic and therapeutic strategies, with the goal of improving patient outcomes and reducing unnecessary or ineffective treatments.

Key facts

Study ID

NCT07516964

Run by

Meyer Children's Hospital IRCCS

People needed

50

Starts

2025-06-10

Expected to finish

2036-10-01

Last updated by the study team

2026-04-08

Who can join

Age: any, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pediatric and adult patients with a diagnosis of podocytopathy
• Patients with nephrotic syndrome and/or histological diagnosis of minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), collapsing glomerulopathy (CG), or diffuse mesangial sclerosis (DMS)
• Both newly diagnosed (incident) patients and patients already under follow-up at participating centers
• Availability of clinical data from medical records (including paper and/or electronic records, laboratory reports, and discharge summaries)
• Availability of biological samples (e.g., blood and/or renal biopsy), if collected as part of routine clinical care
• Signed informed consent by the patient or legal guardian (and assent when applicable)

You may not qualify if…

• Refusal or inability of the patient, parents, or legal guardian to provide informed consent
• Lack of sufficient clinical data or unavailable biological samples required for the study

Where it is running

• Meyer Children's Hospital IRCCS — Florence, FIRENZE, Italy (enrolling)
• Ludwig-Maximilians Universitat — München, Germany
• Ospedale Santa Maria Annunziata — Bagno a Ripoli, Firenze, Italy
• IRCCS Azienda Ospedaliero - Universitaria — Bologna, Italy
• Azienda Ospedaliero Universitaria Careggi — Florence, Italy
• Ospedale S. Giovanni di Dio — Florence, Italy
• IRCCS Istituto Giannina Gaslini — Genova, Italy
• Azienda Ospedaliero-Universitaria di Parma — Parma, Italy
• Azienda Ospedaliero Universitaria Pisana — Pisa, Italy
• Ospedale Santo Stefano — Prato, Italy
• Azienda USL - IRCCS — Reggio Emilia, Italy
• Hospital General de México, Mexico City — Mexico City, Mexico
• Mayo Clinic — Rochester, Minnesota, United States
• Bellvitge University Hospital — Barcelona, Spain

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.